Virus-encoded miR-155 ortholog is an important potential regulator but not essential for the development of lymphomas induced by very virulent Marek's disease virus

Virology

Volumn 448, Issue , 2014, Pages 55-64

  Yu, Zu Hua ^a,b,e   Teng, Man ^a   Sun, Ai Jun ^c   Yu, Le Le ^a   Hu, Bo ^a,b   Qu, Liang Hu ^d   Ding, Ke ^e   Cheng, Xiang Chao ^e   Liu, Ju Xiong ^b   Cui, Zhi Zhong ^c   Zhang, Gai Ping ^a,b   Luo, Jun ^a,e  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b JILIN UNIVERSITY   (China)

^c SHANDONG AGRICULTURAL UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY   (China)

^e HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

BAC; MDV; Mdv1 miR M4; MicroRNA; MiR 155; Oncogenesis; Pathogenesis

Indexed keywords

MICRORNA 155;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CHICKEN; CONTROLLED STUDY; GENE DELETION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA; MARDIVIRUS; MAREK DISEASE; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS MUTANT; VIRUS STRAIN; VIRUS VIRULENCE;

EID: 84886243635     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.09.017     Document Type: Article

References (46)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
2. Boss I.W., Plaisance K.B., Renne R. Role of virus-encoded microRNAs in herpesvirus biology. Trends Microbiol. 2009, 17:544-553.
3. Burgess S.C. Marek's disease lymphomas. Marek's Disease, an Evolving Problem 2004, 98-111. Elsevier Academic Press, Oxford. F. Davison, V. Nair (Eds.).
4. Burnside J., Bernberg E., Anderson A., Lu C., Meyers B.C., Green P.J., Jain N., Isaacs G., Morgan R.W. Marek's disease virus encodes microRNAs that map to meq and the latency-associated transcript. J. Virol. 2006, 80:8778-8786.
5. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
6. Cebrian J., Kaschka-Dierich C., Berthelot N., Sheldrick P. Inverted repeat nucleotide sequences in the genomes of Marek's disease virus and the herpesvirus of the turkey. Proc. Natl. Acad. Sci. U.S.A. 1982, 79:555-558.
7. Coupeau D., Dambrine G., Rasschaert D. Kinetic expression analysis of the cluster mdv1-mir-M9-M4, genes meq and vIL-8 differs between the lytic and latent phases of Marek's disease virus infection. J. Gen. Virol. 2012, 93:1519-1529.
8. Cui Z.Z., Zhuang G.Q., Xu X.Y., Sun A.J., Su S. Molecular and biological characterization of a Marek's disease virus field strain with reticuloendotheliosis virus LTR insert. Virus Genes 2010, 40:236-243.
9. Datsenko K.A., Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:6640-6645.
10. Davison A.J., Eberle R., Ehlers B., Hayward G.S., McGeoch D.J., Minson A.C., Pellett P.E., Roizman B., Studdert M.J., Thiry E. The order Herpesvirales. Arch. Virol. 2009, 154:171-177.
11. Faraoni I., Antonetti F.R., Cardone J., Bonmassar E. miR-155 gene: a typical multifunctional microRNA. Biochim. Biophys. Acta 2009, 1792:497-505.
12. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 2008, 9:102-114.
13. Gottwein E., Mukherjee N., Sachse C., Frenzel C., Majoros W.H., Chi J.T., Braich R., Manoharan M., Soutschek J., Ohler U., Cullen B.R. A viral microRNA functions as an orthologue of cellular miR-155. Nature 2007, 450:1096-1099.
14. Grundhoff A., Sullivan C.S. Virus-encoded microRNAs. Virology 2011, 411:325-343.
15. Kincaid R.P., Sullivan C.S. Virus-encoded microRNAs: an overview and a look to the future. PLoS Pathog. 2012, 8:e1003018.
16. Lee Y.S., Dutta A. MicroRNAs in cancer. Annu. Rev. Pathol. 2009, 4:199-227.
17. Luo J., Teng M., Fan J.M., Wang F.Y., Zhou L., Deng R.G., Zhang G.P. Marek's disease virus-encoded microRNAs: genomics, expression and function. Sci. China Life Sci. 2010, 53:1174-1180.
18. Luo J., Sun A.J., Teng M., Zhou H., Cui Z.Z., Qu L.H., Zhang G.P. Expression profiles of microRNAs encoded by the oncogenic Marek's disease virus reveal two distinct expression patterns in vivo during different phases of disease. J. Gen. Virol. 2011, 92:608-620.
19. Morgan R., Anderson A., Bernberg E., Kamboj S., Huang E., Lagasse G., Isaacs G., Parcells M., Meyers B.C., Green P.J., Burnside J. Sequence conservation and differential expression of Marek's disease virus microRNAs. J. Virol. 2008, 82:12213-12220.
20. Morgan R.W., Burnside J. Roles of avian herpesvirus microRNAs in infection, latency, and oncogenesis. Biochim. Biophys. Acta 2011, 1809:654-659.
21. Muylkens B., Coupeau D., Dambrine G., Trapp S., Rasschaert D. Marek's disease virus microRNA designated Mdv1-pre-miR-M4 targets both cellular and viral genes. Arch. Virol. 2010, 155:1823-1837.
22. Muyrers J.P., Zhang Y., Testa G., Stewart A.F. Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res. 1999, 27:1555-1557.
23. Nair V., Kung H.J. Marek's disease virus oncogenicity: molecular mechanisms. Marek's Disease, an Evolving Problem 2004, 32-48. Elsevier Academic Press, Oxford. F. Davison, V. Nair (Eds.).
24. Narayanan K.R., Williamson Y., Zhang A., Stewart F., Ioannou P.A. Efficient and precise engineering of a 200kb beta-globin human bacterial artificial chromosome in E. coli DH10B using an inducible homologous recombination system. Gene Ther. 1999, 6:442-447.
25. Osterrieder N., Kamil J.P., Schumacher D., Tischer B.K., Trapp S. Marek's disease virus: from miasma to model. Nat. Rev. Microbiol. 2006, 4:283-294.
26. Petherbridge L., Homes K., Baigent S.J., Sacco M.A., Evans S., Osterrieder N., Nair V. Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines. J. Virol. 2003, 77:8712-8718.
27. Petherbridge L., Brown A.C., Baigent S.J., Howes K., Sacco M.A., Osterrieder N., Nair V. Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J. Virol. 2004, 78:13376-13380.
28. Rai D., Kim S.W., McKeller M.R., Dahia P.L., Aguiar R.C. Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:3111-3116.
29. Schumacher D., Tischer B.K., Fuchs W., Osterrieder N. Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J. Virol. 2000, 74:1088-11098.
30. Stik G., Laurent S., Coupeau D., Coutaud B., Dambrine G., Rasschaert D., Muylkens B. A p53-dependent promoter associated with polymorphic tandem repeats controls the expression of a viral transcript encoding clustered microRNAs. RNA 2010, 16:2263-2276.
31. Strassheim S., Stik G., Rasschaert D., Laurent S. mdv1-miR-M7-5p, located in the newly identified first intron of the latency-associated transcript of Marek's disease virus, targets the immediate-early genes ICP4 and ICP27. J. Gen. Virol. 2012, 93:1731-1742.
32. Su S., Cui N., Cui Z., Zhao P., Li Y., Ding J., Dong X. Complete genome sequence of a recombinant Marek's disease virus field strain with one reticuloendotheliosis virus long terminal repeat insert. J. Virol. 2012, 86:13818-13819.
33. Sun A.J., Petherbridge L., Zhao Y.G., Li Y.P., Nair V., Cui Z.Z. A BAC clone of MDV strain GX0101 with REV-LTR integration retained its pathogenicity. Chin. Sci. Bull. 2009, 54:2641-2647.
34. Sun A.J., Xu X.Y., Petherbridge L., Zhao Y.G., Nair V., Cui Z.Z. Functional evaluation of the role of reticuloendotheliosis virus long terminal repeat (LTR) integrated into the genome of a field strain of Marek's disease virus. Virology 2010, 397:270-276.
35. Tili E., Croce C.M., Michaille J.J. miR-155: on the crosstalk between inflammation and cancer. Int. Rev. Immunol. 2009, 28:264-284.
36. Waidner L.A., Morgan R.W., Anderson A.S., Bernberg E.L., Kamboj S., Garcia M., Riblet S.M., Ouyang M., Isaacs G.K., Markis M., Meyers B.C., Green P.J., Burnside J. MicroRNAs of Gallid and Meleagrid herpesviruses show generally conserved genomic locations and are virus-specific. Virology 2009, 388:128-136.
37. Witter R.L. Increased virulence of Marek's disease virus field isolates. Avian Dis. 1997, 41:149-163.
38. Witter R.L., Schat K. Marek's disease. Diseases of Poultry 2003, 407-464. Iowa State University Press, Ames. Y.M. Saif (Ed.).
39. Xu S., Xue C., Li J., Bi Y., Cao Y. Marek's disease virus type 1 microRNA miR-M3 suppresses cisplatin-induced apoptosis by targeting Smad2 of the transforming growth factor beta signal pathway. J. Virol. 2011, 85:276-285.
40. Yao Y., Zhao Y., Xu H., Smith L.P., Lawrie C.H., Sewer A., Zavolan M., Nair V. Marek's disease virus type 2 (MDV-2)-encoded microRNAs show no sequence conservation with those encoded by MDV-1. J. Virol. 2007, 81:7164-7170.
41. Yao Y., Zhao Y., Xu H., Smith L.P., Lawrie C.H., Watson M., Nair V. MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs. J. Virol. 2008, 82:4007-4015.
42. Yao Y., Zhao Y., Smith L.P., Watson M., Nair V. Novel microRNAs (miRNAs) encoded by herpesvirus of turkeys: evidence of miRNA evolution by duplication. J. Virol. 2009, 83:6969-6973.
43. Yin Q., Wang X., Fewell C., Cameron J., Zhu H., Baddoo M., Lin Z., Flemington E.K. MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation. J. Virol. 2010, 84:6318-6327.
44. Zhao Y., Petherbridge L., Smith L.P., Baigent S., Nair V. Self-excision of the BAC sequences from the recombinant Marek's disease virus genome increases replication and pathogenicity. Virol. J. 2008, 5:19.
45. Zhao Y., Xu H., Yao Y., Smith L.P., Kgosana L., Green J., Petherbridge L., Baigent S.J., Nair V. Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas. PLoS Pathog. 2011, 7:e1001305.
46. Zhao Y., Yao Y., Xu H., Lambeth L., Smith L.P., Kgosana L., Wang X., Nair V. A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus. J. Virol. 2009, 83:489-492.